Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
51 - 59 out of 59Page size: 10
  1. 2012
  2. Published

    Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma

    Martino, A., Campa, D., Canzian, F., Jamroziak, K., Szemraj-Rogucka, Z., Reis, R. M., Marques, H., Sainz, J., Jurado, M., Ríos, R., Buda, G., Orciuolo, E., Petrini, M., García-Sanz, R., Lesueur, F., Moreno, V., Szemraj, J., Tjønneland, A., Overvad, K., Vangsted, A. J. & 11 others, Vogel, U. B., Mikala, G., Kádár, K., Szombath, G., Varkonyi, J., Dumontet, C., Gemignani, F., Rossi, A. M., Landi, S., Houlston, R. S. & Hemminki, K., 1 Sep 2012, In: British Journal of Haematology. 158, 6, p. 805-809 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma

    Vangsted, Annette Juul, Nielsen, K. R., Klausen, T. W., Haukaas, E., Tjønneland, A. & Vogel, U. B., 1 Aug 2012, In: British Journal of Haematology. 158, 4, p. 515-518 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Genetic variations in multiple myeloma II: Association with effect of treatment

    Vangsted, Annette Juul, Klausen, T. W. & Vogel, U., 1 Feb 2012, In: European Journal of Haematology. 88, 2, p. 93-117 25 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Genetic variations in multiple myeloma I: Effect on risk of multiple myeloma

    Vangsted, Annette Juul, Klausen, T. W. & Vogel, U. B., 1 Jan 2012, In: European Journal of Haematology. 88, 1, p. 8-30 23 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2011
  7. Published

    Interferon-alpha in the treatment of multiple myeloma

    Khoo, T. L., Joshua, D., Gibson, J. & Vangsted, Annette Juul, 1 Jan 2011, In: Current Drug Targets. 12, 3, p. 437-446 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2010
  9. Published

    Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⿻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

    Brimnes, M. K., Vangsted, Annette Juul, Knudsen, L. M., Gimsing, P., Gang, Uffe Jakob Ortved, Johnsen, H. & Svane, Inge Marie, 2010, In: Scandinavian Journal of Immunology. 72, 6, p. 540-7

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. 2009
  11. Published

    A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support

    Vangsted, Annette Juul, Klausen, T. W., Gimsing, P., Andersen, N. F., Abildgaard, N., Gregersen, H. & Vogel, U., 2009, In: Haematologica. 94, 9, p. 1274-81 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Bisfosfonatassocieret osteonekrose i kaeberne hos patienter med myelomatose

    Lund, T., Gregersen, H., Vangsted, Annette Juul, Marker, P. & Abildgaard, N., 2009, In: Ugeskrift for læger. 171, 1-2, p. 50-2 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. 2008
  14. Published

    The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT

    Vangsted, Annette Juul, Klausen, T. W., Ruminski, W., Gimsing, P., Andersen, N. F., Gang, A. O., Abildgaard, N., Knudsen, L. M., Nielsen, J. L., Gregersen, H. & Vogel, U., 2008, In: Bone Marrow Transplantation. 43, 7, p. 539-45 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 Next

ID: 9762536